HC
IDXX icon

Hurley Capital’s Idexx Laboratories IDXX Stock Holding History

Hurley Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22
Closed -$14.9K – 716
2025
Q4 		$14.9K Sell
22
-1
-4% -$681 0.01% 287
2025
Q3 		$14.7K Buy
23
+1
+5% +$607 0.01% 316
2025
Q2 		$11.8K Hold
22
– – 0.01% 292
2025
Q1 		$9.24K Sell
22
-47
-68% -$20.4K 0.01% 330
2024
Q4 		$28.7K Buy
+69
New +$30.3K 0.02% 190

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hurley Capital's IDXX Position: Q1 2026 in Review

Hurley Capital sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 22 shares — an estimated $14.9K sold.

Hurley Capital first reported a position in IDXX in Q4 2024 and held it in 5 quarters. The position peaked at $28.7K in Q4 2024. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Hurley Capital reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Hurley Capital sold 22 Idexx Laboratories shares in Q1 2026, an estimated $14.9K.
  • Hurley Capital first reported a position in Idexx Laboratories in Q4 2024 and held it in 5 quarters.
  • Hurley Capital's Idexx Laboratories position peaked at $28.7K in Q4 2024.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.